SKYHAWK THERAPEUTICS
Skyhawk Therapeutics is a provvider of small molecule therapeutics designed to offer therapies that correct RNA expression.The company's therapeutics use proprietary technology that helps the rational design of small molecules that target specific binding pocket regions on RNA, using both sequence and structural specificity, at particular moments in the RNA splicing process, enabling physicians to target diseases driven by a type of RNA mis-splicing called exon skipping.
SKYHAWK THERAPEUTICS
Industry:
Biotechnology Therapeutics
Founded:
2016-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.skyhawktx.com
Total Employee:
11+
Status:
Active
Contact:
617.858.0041
Total Funding:
181.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Wordpress Plugins
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Advisors List
Board_member
2018-01-01
Board_member
Board_member
Advisor
2018-01-01
Board_member
Board_member
Current Employees Featured
Elliot Ehrich Chief Medical Officer @ Skyhawk Therapeutics
Chief Medical Officer
2020-10-01
Maura McCarthy VP Corporate Development @ Skyhawk Therapeutics
VP Corporate Development
2016-01-01
Kathleen McCarthy CEO @ Skyhawk Therapeutics
CEO
Bill Haney Co-Founder & CEO @ Skyhawk Therapeutics
Co-Founder & CEO
2016-10-01
Gary Martell CFO @ Skyhawk Therapeutics
CFO
2017-10-01
Founder
Investors List
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Venture Round - Skyhawk Therapeutics
Good Growth Capital
Good Growth Capital investment in Series A - Skyhawk Therapeutics
Alexandria Venture Investments
Alexandria Venture Investments investment in Venture Round - Skyhawk Therapeutics
ShangPharma Innovation
ShangPharma Innovation investment in Venture Round - Skyhawk Therapeutics
Agent Capital
Agent Capital investment in Venture Round - Skyhawk Therapeutics
Tim Disney
Tim Disney investment in Venture Round - Skyhawk Therapeutics
GreatPoint Ventures
GreatPoint Ventures investment in Venture Round - Skyhawk Therapeutics
The Duke of Bedford
The Duke of Bedford investment in Venture Round - Skyhawk Therapeutics
Celgene
Celgene investment in Venture Round - Skyhawk Therapeutics
Good Growth Capital
Good Growth Capital investment in Series A - Skyhawk Therapeutics
Official Site Inspections
http://www.skyhawktx.com Semrush global rank: 5.01 M Semrush visits lastest month: 1.67 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Skyhawk Therapeutics"
Home | Skyhawk Therapeutics
SKYHAWK is the clinic with SKY-0515, targeting Huntington's Disease. Our next two internal neurology programs, SKY-1300 and SKY-1500, address Spinocerebellar Ataxia Type 3, and Frontotemporal Dementia (FTD) …See details»
About | Skyhawk Therapeutics
Sergey Paushkin, M.D., Ph.D., is a scientific co-founder of Skyhawk. He has more than 20 years of experience in the discovery and development of small molecules targeting RNA including …See details»
Skyhawk Therapeutics - Crunchbase Company Profile …
Contact Email info@skyhawktx.com Phone Number 617.858.0041 Skyhawk Therapeutics is a provvider of small molecule therapeutics designed to offer therapies that correct RNA expression.The company's therapeutics use …See details»
Skyhawk therapeutics - Switzerland Innovation Park …
Skyhawktx.com. view all Alumni. Contact. Switzerland Innovation Park Basel Area AG Hegenheimermattweg 167A 4123 Allschwil, Switzerland +41 61 577 23 16 baselarea@switzerland-innovation.com. Parks. Foundation; Park …See details»
Skyhawk Therapeutics - Overview, News & Similar companies
Skyhawk Therapeutics contact info: Phone number: (617) 858-0041 Website: www.skyhawktx.com What does Skyhawk Therapeutics do? Founded in 2015, Skyhawk …See details»
Skyhawk Therapeutics Presents Compelling Preclinical Data on SKY …
BOSTON, MA., October 24, 2024 - Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate critical RNA …See details»
Skyhawk Therapeutics Overview | SignalHire Company Profile
Skyhawk Therapeutics is a drug discovery and development company focused on revolutionizing disease treatment with small molecules that modify RNA expression. Our founders are leading …See details»
Working At Skyhawk Therapeutics: Company Overview and …
Mar 14, 2024 skyhawktx.com. Organization Type. Private. CEO. William Haney. Social Media. Skyhawk Therapeutics is focused on discovering, developing and commercializing therapies …See details»
Skyhawk - VentureRadar
"Skyhawk's is developing small molecule therapeutics that correct RNA expression.Their proprietary technology enables the rational design of small molecules that target the RNA …See details»
Skyhawk Therapeutics - Work in biotech
Skyhawk Therapeutics is developing small molecules that modify RNA expression to revolutionize disease treatment. Many diseases are underpinned by changes in RNA expression - Skyhawk …See details»
Skyhawk Therapeutics Has Advanced to the Multiple Ascending …
Feb 28, 2024 Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule RNA splicing modifiers, today announced that the Phase 1 multiple …See details»
Skyhawk Therapeutics, Inc. (Skyhawk Therapeutics, Inc.) - 药物管 …
Australian Human Research Ethics Committees approves SKY-0515 treatment for up to 12 weeks in the company's ongoing Phase 1 trial in patients with Huntington's Disease Volumetric MRI …See details»
Skyhawk Therapeutics Presents Compelling Preclinical Data on SKY …
BOSTON, Oct. 24, 2024 /PRNewswire/ — Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate …See details»
Skyhawk Therapeutics Presents Compelling Preclinical Data at the ...
BOSTON, Oct. 24, 2024 /PRNewswire/ -- Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate …See details»
Skyhawk Therapeutics · GitHub
SkyhawkTx. Product Actions. Automate any workflow Packages. Host and manage packages Security. Find and fix vulnerabilities Codespaces. Instant dev environments ... This …See details»
Skyhawk Therapeutics to Present Preclinical Data of SKY-1214 ...
BOSTON, Nov. 21, 2024 /PRNewswire/-- Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate …See details»
Skyhawk Therapeutics Presents Compelling Preclinical Data on SKY …
BOSTON, MA, USA I October 24, 2024 I Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate …See details»
Skyhawk Receives Australian Regulatory Approval to Extend SKY …
BOSTON, Dec. 9, 2024 /PRNewswire/ -- Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company, today announced that the Australian Human Research Ethics …See details»
The Starbase rocket testing facility is permanently changing the ...
1 day ago A mural of Elon Musk in Brownsville, Texas. Robert Kopack A laboratory near the community. At the end of the day, to develop a rocket, you need a place to test your design.See details»
Merck doubles down on Skyhawk’s tech to drug RNA, promising …
Maura@skyhawktx.com. Full Article. Recent Posts See All. Skyhawk Receives Australian Regulatory Approval to Extend SKY-0515 Treatment Duration in Phase 1 Huntington's …See details»